UNH vs VRTX
By Alex · Tickerpine
UnitedHealth Group Incorporated vs Vertex Pharmaceuticals Incorporated, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | UNH | VRTX |
|---|---|---|
| Price | $427.89 | $491.34 |
| Market cap | $388.59B | $124.70B |
| P/E ratio | 32.3 | 29.2 |
| ROE | 12.18% | 24.20% |
| Profit margin | 2.68% | 35.51% |
| Revenue growth | 2.00% | 7.80% |
| Dividend yield | 2.17% | — |
| Beta | 0.65 | 0.31 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
UNH vs VRTX in plain English
- UNH is the bigger company — about 3.1× the market cap of VRTX.
- VRTX is cheaper on earnings (P/E 29.2 vs 32.3).
- VRTX earns a higher return on equity (24% vs 12%).
- VRTX is growing revenue faster (8% vs 2%).
- UNH pays a dividend (2.17%) while the other effectively doesn't.
How would $1,000 have done in each?
UNH return calculator
See what $1,000 in UnitedHealth Group Incorporated would be worth today.
VRTX return calculator
See what $1,000 in Vertex Pharmaceuticals Incorporated would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.